Equibles does not estimate personal net worth.
Get an email with a short summary when Capricor Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CAPR alertsAJ Bergmann is recorded as CFO at Capricor Therapeutics, Inc. (CAPR). AJ Bergmann has spoken on 14 earnings calls across 1 company, most recently for Capricor Therapeutics, Inc. on November 10, 2026. Capricor Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Capricor Therapeutics, Inc. includes Linda Marban (CEO and Board Member), Frank Litvack (Chairman and Board Member), Anthony "A.J." Bergmann (CFO) and 7 others.
“Before we begin, I'd like to remind you that any statements made during today's call are not historical and are considered to be forward-looking statements.”
“As of June 30, 2026, Capricor had cash, cash equivalents, and marketable securities totaling approximately $237.9 million, and there was no revenue recognized for the second quarter of 2026 or 2025.”
“Before we start, I would like to state that we will be making certain forward-looking statements during today’s presentation.”
“Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.”
“Before we start, I would like to state that we will be making certain forward-looking statements during today’s call and presentation.”
Biotechnology · Healthcare
CFO
